1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Prostatism: new trials by email Literature Review of Prostatism trials Research Report on Prostatism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy Microcannula Harvest Adipose, Centricyte 1000, IV Sterile Normal Saline - BPH, Nocturia | Phase 1 / Phase 2 | Withdrawn | Robert W. Alexander, MD, FICS | 2019-11-01 | 2021-01-12 | |
| The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate Ozarelix, Placebo - Benign Prostatic Hypertrophy | Phase 2 | Completed | Spectrum Pharmaceuticals, Inc | 74 | 2007-01-23 | 2021-10-15 |
Bronchiolitis Obliterans Syndrome (1) · Nocturia (1) · Prostatic Hyperplasia (1) · Prostatitis (1)
Genital Diseases (2) · Genital Diseases, Male (2) · Lower Urinary Tract Symptoms (2) · Male Urogenital Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Prostatic Diseases (2) · Signs and Symptoms (2) · Urogenital Diseases (2) · Urological Manifestations (2) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Graft vs Host Disease (1) · Immune System Diseases (1)
ozarelix (1)
Robert W. Alexander, MD, FICS (1) · Spectrum Pharmaceuticals, Inc (1)
United States (2)